Wellington people with multiple sclerosis are wanted for an international clinical trial of a new drug, Natalizumab, which may slow the progress of the debilitating disease.
The Wellingtonians will be part of a trial of 900 people worldwide that starts at the end of June, and 10 people are needed.
Those interested should contact Dr Abermethy at Wellington Hospital.
